SES AI (SES) Investor presentation summary

Strategic positioning and market opportunity

• AI-driven solutions address slow adoption in battery R&D and safety, integrating software and hardware for precise health monitoring.

• Energy storage system (ESS) market projected to be 10x the size of EV market within 10 years, with global ESS battery shipments rising from 300 GWh in 2024 to 1,400 GWh in 2030.

• Military drone battery market expected to grow from $9.5bn in 2025 to $21.8bn in 2030.

• Core intellectual property in Molecular Universe platform provides competitive advantages and robust private market valuation comparables.

• Revenue of $16.4 million in first three quarters of 2025, with full-year guidance of $20–25 million and liquidity of $214 million as of September 30, 2025.

Technology and product development

• Molecular Universe AI4Science platform accelerates battery material discovery, health management, and product development.

• Six novel electrolyte materials discovered, each tailored for specific applications such as EVs, drones, heavy-duty trucking, consumer electronics, and ESS.

• High energy and power density Li-Metal and Li-ion cells for drones, with energy density up to 500 Wh/kg and scalable NDAA-compliant manufacturing.

• Integrated hardware/software ESS solutions with battery health monitoring, leveraging real-world data from UZ Energy's global customer base.

• Automated lab integration, proprietary simulation engines, and machine learning models enhance R&D productivity and predictive accuracy.

Business model and growth initiatives

• Capex-light approach focuses on ESS, drones, and materials, with R&D concentrated in the Molecular Universe platform.

• Three business units established: ESS, Drones, and Materials, each targeting revenue generation, while Molecular Universe focuses on value creation.

• Commercial partnerships and JVs (e.g., with Hisun and Top Material) enable scale and market access for materials and drone cells.

• Expansion of NDAA-compliant cell production in Korea from 300K to 1M cells/year, with additional contract manufacturing capacity for non-US markets.

• Six electrolyte discoveries in commercial qualification, with a pipeline of ~30 more, supporting long-term growth beyond 2026.